col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


78 Results       Page 1

 [1] 
Wiley: Liver International
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―19 NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare Database Jonathan F. Brozat, Fady Ntanios, Deepa Malhotra, Simon Dagenais, Nino Katchiuri, Birol Emir, Frank Tacke
2 [GO] 2023―Sep―22 Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach Loreta A. Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla, Valentina Gallinaro, et al. (+2)
3 [GO] 2023―Sep―22 Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts Giuseppe Marrone, Marcello Covino, Giuseppe Merra, Andrea Piccioni, Annamaria Amodeo, Angela Novelli, et al. (+4)
4 [GO] 2023―Jun―30 Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021 Donghee Kim, Richie Manikat, George Cholankeril, Aijaz Ahmed
5 [GO] 2023―Jun―29 Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children Teng Liu, Jian-She Wang
6 [GO] 2023―Mar―17 Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients Marzia Montalbano, Paola Piccolo, Raffaella Lionetti, Ubaldo Visco-Comandini, Chiara Agrati, Germana Grassi, et al. (+12)
7 [GO] 2022―Sep―06 No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio
8 [GO] 2022―Aug―25 No impact of Covid-19 epidemic on decompensation of alcoholic liver disease: results from a single-center in Milan Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio
9 [GO] 2022―Aug―20 Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: a systematic review and meta-analysis De Luo, Xinpei Chen, Juan Du, Bingjie Mei, Ankang Wang, Fei Kuang, et al. (+7)
10 [GO] 2022―Jul―23 HCV point of care screening in people tested for SARS-CoV -2 in a social-housing neighbourhood of Milan, Italy Martina Beltrami, Gabriele Pagani, Federico Conti, Laura Pezzati, Giacomo Casalini, Rossana Rondanin, et al. (+4)
11 [GO] 2022―Jul―20 Third Dose of mRNA COVID-19 Vaccine and response: Correspondence Pathum Sookaromdee, Viroj Wiwanitkit
12 [GO] 2022―Jun―28 Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine - no longer exclusive to mRNA vaccine? Shahreedhan Shahrani, Sooi Choong Yeong, Ida Normiha Hilmi, Sanjiv Mahadeva
13 [GO] 2022―Jun―09 Mycophenolate and SARS-CoV -2 vaccination: Mixing oil and water Marisol Arenas-De Larriva, Manuel L. Rodríguez-Perálvarez
14 [GO] 2022―Jun―09 Sars-Cov -2 vaccination in liver transplant recipients: The ‘holy grail’ in a hostile environment Patrizia Burra, Francesco Paolo Russo
15 [GO] 2022―Jun―07 Response to: “No Impact of Covid-19 Pandemic on Decompensation of Alcoholic Liver Disease: Results from a Single Center in Milan” Humberto C. Gonzalez, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon
16 [GO] 2022―May―28 Screening for hepatitis C at the time of the pandemic: Need to adjust the shot Pietro Torre, Carmine Coppola, Mario Masarone, Marcello Persico
17 [GO] 2022―May―24 Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi-Zamparelli, José Ríos, et al. (+49)
18 [GO] 2022―Apr―08 Hepatitis C screening during SARS-CoV -2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno Pietro Torre, Monica Annunziata, Roberta Sciorio, Carmine Coppola, Mario Masarone, Marcello Persico
19 [GO] 2022―Mar―28 Quality of life in liver transplant recipients during the Corona Virus Disease 19 pandemic: a multicenter study Stefano Gitto, Lucia Golfieri, Nicolò Mannelli, Maria Rosa Tamè, Ivo Lopez, Roberta Ceccato, et al. (+45)
20 [GO] 2022―Mar―26 Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV -2 vaccine in liver transplant recipients Lucy Meunier, Mathilde Sanavio, Jérôme Dumortier, Magdalena Meszaros, Stéphanie Faure, José Ursic Beodya, et al. (+4)
21 [GO] 2022―Feb―23 Nintedanib induced liver injury: Not every liver injury is virus or vaccine-induced in the era of COVID-19 Anuraag Jena, Tanushi Aggarwal, Suvradeep Mitra, Anupam Kumar Singh
22 [GO] 2022―Feb―07 Vaccination against COVID-19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis Luis Antonio Díaz, Eduardo Fuentes-López, Mariana Lazo, Patrick S. Kamath, Marco Arrese, Juan Pablo Arab
23 [GO] 2022―Feb―02 Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection Taiyu He, Yingzhi Zhou, Pan Xu, Ning Ling, Min Chen, Tianquan Huang, et al. (+28)
24 [GO] 2022―Jan―30 Alcohol-related hepatitis admissions increased 50% in the first months of the CoViD -19 pandemic in the US Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon
25 [GO] 2022―Jan―29 Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? Benedetta Terziroli Beretta-Piccoli, Ana Lleo
26 [GO] 2022―Jan―07 Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease Hideki Fujii, Naotoshi Nakamura, Shinya Fukumoto, Tatsuo Kimura, Akemi Nakano, Yuji Nadatani, et al. (+6)
27 [GO] 2021―Dec―16 Is it time to get rid of the biopsy mandate in adults with suspected Autoimmune hepatitis? Lessons from the COVID-19 pandemic. Ali Ibrahim Shorbagi
28 [GO] 2021―Nov―30 Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis Cumali Efe, Craig Lammert, Koray Taşçılar, Renumathy Dhanasekaran, Berat Ebik, Fatima Higuera-de la Tijera, et al. (+74)
29 [GO] 2021―Nov―01 A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence? Anestis Goulas, Georgia Kafiri, Hariklia Kranidioti, Spilios Manolakopoulos
30 [GO] 2021―Oct―31 Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco-Comandini, Concetta Castilletti, Vincenzo Puro, Paola Piccolo, et al. (+12)
31 [GO] 2021―Oct―08 Reshape and secure HCC managing during COVID-19 pandemic: a single center analysis of four periods in 2020 versus 2019 Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, Matilde Topa, Angelo Sangiovanni, Andrea Gori, et al. (+4)
32 [GO] 2021―Oct―07 Aspartate aminotransferase in COVID-19: A probably overrated marker Elena Aloisio, Mauro Panteghini, Luca Valenti
33 [GO] 2021―Sep―30 Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: an interrupted time series analysis Mawuena Binka, Sofia Bartlett, Héctor Alexander Velásquez García, Maryam Darvishian, Dahn Jeong, Prince Adu, et al. (+7)
34 [GO] 2021―Sep―23 COVID-19, adaptative immune response and metabolic associated liver disease Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, et al. (+3)
35 [GO] 2021―Sep―03 Autoimmune hepatitis triggered by COVID-19: A report of two cases Gökhan Kabaçam, Staffan Wahlin, Cumali Efe
36 [GO] 2021―Aug―29 PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system Carlos J Pirola, Silvia Sookoian
37 [GO] 2021―Jul―05 Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: a web-based survey Francesca Romana Ponziani, Alessio Aghemo, Giuseppe Cabibbo, Mario Masarone, Sara Montagnese, Salvatore Petta, et al. (+55)
38 [GO] 2021―Jun―22 COVID-19 and the liver - Lessons learned Toni Herta, Thomas Berg
39 [GO] 2021―Jun―21 COVID-19 And The Liver: a 2021 Update CW Spearman, A Aghemo, L Valenti, MW Sonderup
40 [GO] 2021―Jun―01 Hepatitis C Elimination in Sweden: Progress, Challenges and Opportunities for Growth in the time of COVID-19 S Blach, M Blomé, A-S Duberg, A Jerkeman, M Kåberg, P-E Klasa, et al. (+4)
41 [GO] 2021―May―21 Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19 Simon Bütikofer, Daniela Lenggenhager, Pedro David Wendel Garcia, Ewerton Marques Maggio, Martina Haberecker, Cäcilia S. Reiner, et al. (+6)
42 [GO] 2021―Apr―07 Liver involvement in Children with SARS-COV-2 Infection: Two Distinct Clinical Phenotypes Caused by the Same Virus Adriana Pere, Amanda Cantor, Bryan Rudolph, Jonathan Miller, Debora Kogan-Liberman, Qi Gao, et al. (+4)
43 [GO] 2021―Feb―05 Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection Adeel A. Butt, Peng Yan, Rashid A. Chotani, Obaid S. Shaikh
44 [GO] 2020―Dec―23 Clinical Characteristics of COVID-19 Patients with Hepatitis B Virus Infection - a Retrospective Study Rui Liu, Li Zhao, Xiaoming Cheng, Han Huan, Cong Li, Dong Li, et al. (+7)
45 [GO] 2020―Nov―17 Genetic insight into COVID-19 related liver injury: a note on MBOAT7 Antonia Machill, Robert Bals, Frank Lammert, Marcin Krawczyk
46 [GO] 2020―Nov―15 Pathophysiological mechanisms of liver injury in COVID-19 Alexander D. Nardo, Mathias Schneeweiss-Gleixner, May Bakail, Emmanuel D. Dixon, Sigurd F. Lax, Michael Trauner
47 [GO] 2020―Nov―07 COVID-19 and liver disease: not all evil comes to harm Elisa Marabotto, Sebastiano Ziola, Afscin Djahandideh Sheijani, Edoardo G. Giannini
48 [GO] 2020―Oct―24 Genetic insight into Covid-19 related liver injury Cristiana Bianco, Guido Baselli, Francesco Malvestiti, Luigi Santoro, Serena Pelusi, Maria Manunta, et al. (+5)
49 [GO] 2020―Oct―02 Rates and Characteristics of SARS-CoV-2 Infection in Persons with Hepatitis C Virus Infection Adeel A. Butt, Peng Yan
50 [GO] 2020―Jul―17 Value-based medicine, a compass to guide health care decisions in the COVID-19 aftermath Mario Strazzabosco
51 [GO] 2020―Jul―17 Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE) Marta Colaneri, Pietro Valsecchi, Luciano Perotti, Serena Ludovisi, Elena Seminari, Teresa Chiara Pieri, et al. (+2)
52 [GO] 2020―Jun―25 Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience Nikroo Hashemi, Kathleen Viveiros, Walker D. Redd, Joyce C. Zhou, Thomas R. McCarty, Ahmad Najdat Bazarbashi, et al. (+5)
53 [GO] 2020―Jun―23 Metabolic associated fatty liver disease is associated with severity of COVID-19 Yu-Jie Zhou, Kenneth I. Zheng, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, et al. (+4)
54 [GO] 2020―Jun―19 Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng
55 [GO] 2020―Jun―11 Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 Salvatore Piano, Andrea Dalbeni, Elia Vettore, Devis Benfaremo, Massimo Mattioli, Carmine Gabriele Gambino, et al. (+25)
56 [GO] 2020―Jun―11 A letter of solidarity during the COVID-19 Pandemic Jeffrey V. Lazarus, Francesco Negro, Manal El-Sayed, Massimo Colombo
57 [GO] 2020―Jun―04 Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry? Magdalena Meszaros, Lucy Meunier, David Morquin, Kada Klouche, Pierre Fesler, Emilie Malezieux, et al. (+4)
58 [GO] 2020―May―29 Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience Anita Verma, Shirin Elizabeth Khorsandi, Annalisa Dolcet, Andreas Prachalias, Abid Suddle, Nigel Heaton, Wayel Jassem
59 [GO] 2020―May―23 Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS-Cov-2? Leonardo da Fonseca, Flair José Carrilho
60 [GO] 2020―May―21 SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure Karsten Große, Matthijs Kramer, Christian Trautwein, Tony Bruns
61 [GO] 2020―May―20 COVID-19 and liver cancer clinical trials: not everything is lost Antonio D’Alessio, Nicola Personeni, Tiziana Pressiani, Silvia Bozzarelli, Valeria Smiroldo, Matteo Simonelli, et al. (+3)
62 [GO] 2020―May―17 First case of drug-induced liver injury (DILI) associated with the use of tocilizumab in a patient with COVID-19 Damir Muhović, Jelena Bojović, Ana Bulatović, Batrić Vukčević, Marina Ratković, Ranko Lazović, Brigita Smolović
63 [GO] 2020―May―16 Management of Hepatocellular Cancer in the time of SARS-CoV-2 Rohini Sharma, David J. Pinato
64 [GO] 2020―May―11 Liver injury in COVID-19: diagnosis and associated factors - authors' reply Ningfang Lian, Su Lin, Hansheng Xie
65 [GO] 2020―May―05 Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) He Qiu, Praneet Wander, David Bernstein, Sanjaya K. Satapathy
66 [GO] 2020―May―02 Liver injury in COVID-19: diagnosis and associated factors Zheng Ye, Bin Song
67 [GO] 2020―Apr―30 SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19 Carlos J Pirola, Silvia Sookoian
68 [GO] 2020―Apr―29 Author response to Letter to the Editor “Liver impairment associated with disease progression in COVID-19 patients” Yafei Zhang, Lan Liu, Qiu Zhao
69 [GO] 2020―Apr―22 COVID-19 and viral hepatitis elimination programs: Are we stepping backward? Hamidreza Karimi-Sari, Mohammad Saeid Rezaee-Zavareh
70 [GO] 2020―Apr―19 Potential implications of COVID-19 in non-alcoholic fatty liver disease Grietje H. Prins, Peter Olinga
71 [GO] 2020―Apr―18 Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis Panagiotis Paliogiannis, Angelo Zinellu
72 [GO] 2020―Apr―15 Liver impairment associated with disease progression in COVID-19 patients Peng Chen, Jiexin Lei, Yue Wu, Gang Liu, Benhong Zhou
73 [GO] 2020―Apr―06 COVID-19 and liver disease Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti
74 [GO] 2020―Apr―05 Coronavirus disease 2019 (COVID-19) and prevalence of chronic liver disease: A meta-analysis Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni
75 [GO] 2020―Apr―05 Let’s not forget our COVID-19-free cirrhotic patients! Mauro Viganò, Marco Carbone
76 [GO] 2020―Apr―02 Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China Yafei Zhang, Liang Zheng, Lan Liu, Mengya Zhao, Jun Xiao, Qiu Zhao
77 [GO] 2020―Apr―02 Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury:A Retrospective study Hansheng Xie, Jianming Zhao, Ningfang Lian, Su Lin, Qunfang Xie, Huichang Zhuo
78 [GO] 2020―Mar―14 Liver injury during highly pathogenic human coronavirus infections Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng
 [1] 

78 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec